CA
VRCA icon

Cliff Asness’s Verrica Pharmaceuticals VRCA Stock Holding History

Cliff Asness’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,027
Closed -$26.6K – 3605
2025
Q2 		$26.6K Sell
5,027
-844
-14% -$4.54K ﹤0.01% 3270
2025
Q1 		$26K Buy
5,871
+4,427
+307% +$28.6K ﹤0.01% 3118
2024
Q4 		$10.1K Buy
+1,444
New +$15.9K ﹤0.01% 2854
2024
Q1 		– Sell
-2,236
Closed -$164K – 2508
2023
Q4 		$164K Buy
2,236
+39
+2% +$1.6K ﹤0.01% 2238
2023
Q3 		$85.3K Buy
+2,197
New +$112K ﹤0.01% 2243

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Cliff Asness's VRCA Position: Q3 2025 in Review

Cliff Asness sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 5,027 shares — an estimated $26.6K sold.

Cliff Asness first reported a position in VRCA in Q3 2023 and held it in 5 quarters. The position peaked at $164K in Q4 2023. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • Cliff Asness reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Cliff Asness sold 5,027 Verrica Pharmaceuticals shares in Q3 2025, an estimated $26.6K.
  • Cliff Asness first reported a position in Verrica Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • Cliff Asness's Verrica Pharmaceuticals position peaked at $164K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.